{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:34:24Z","timestamp":1781649264122,"version":"3.54.5"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,15]]},"DOI":"10.7759\/cureus.107123","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T01:06:40Z","timestamp":1776301600000},"source":"Crossref","is-referenced-by-count":1,"title":["Severe Hyperammonemic Encephalopathy Following Sustained-Release Sodium Valproate Overdose: A Case Report"],"prefix":"10.7759","author":[{"given":"Shotaro","family":"Ban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiaki","family":"Toida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Onuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Morimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2007.06.015","article-title":"The measurement of ammonia blood levels in patients taking valproic acid: looking for problems where they do not exist?","volume":"11","author":"Chicharro AV","year":"2007","unstructured":"Chicharro AV, de Marinis AJ, Kanner AM. The measurement of ammonia blood levels in patients taking valproic acid: looking for problems where they do not exist?. Epilepsy Behav. 2007, 11:361-6. 10.1016\/j.yebeh.2007.06.015","journal-title":"Epilepsy Behav"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.1557","article-title":"Valproic-induced hyper ammonemic encephalopathy in a known case of epilepsy","volume":"9","author":"Imam SF","year":"2017","unstructured":"Imam SF, Lodhi OUH, Zafar R, Nasim S, Malik WT. Valproic-induced hyper ammonemic encephalopathy in a known case of epilepsy. Cureus. 2017, 9:e1557. 10.7759\/cureus.1557","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001689","article-title":"Valproic acid-associated hyperammonemia: a systematic review","volume":"43","author":"Wong YJ","year":"2023","unstructured":"Wong YJ, Fan J, Wan A, Mihic T, Gnyra M. Valproic acid-associated hyperammonemia: a systematic review. J Clin Psychopharmacol. 2023, 43:283-94. 10.1097\/JCP.0000000000001689","journal-title":"J Clin Psychopharmacol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2005.02.015","article-title":"L-carnitine was safely administered in the setting of valproate toxicity","volume":"23","author":"LoVecchio F","year":"2005","unstructured":"LoVecchio F, Shriki J, Samaddar R. L-carnitine was safely administered in the setting of valproate toxicity. Am J Emerg Med. 2005, 23:321-2. 10.1016\/j.ajem.2005.02.015","journal-title":"Am J Emerg Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/15563650903167772","article-title":"Extracorporeal elimination in acute valproic acid poisoning","volume":"47","author":"Thanacoody RHK","year":"2009","unstructured":"Thanacoody RHK. Extracorporeal elimination in acute valproic acid poisoning. Clin Toxicol (Phila). 2009, 47:609-16. 10.1080\/15563650903167772","journal-title":"Clin Toxicol (Phila)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2015.1035441","article-title":"Extracorporeal treatment for valproic acid poisoning: systematic review and recommendations from the EXTRIP workgroup","volume":"53","author":"Ghannoum M","year":"2015","unstructured":"Ghannoum M, Lalibert\u00e9 M, Nolin TD, MacTier R, Lavergne V, Hoffman RS, Gosselin S. Extracorporeal treatment for valproic acid poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin Toxicol (Phila). 2015, 53:454-65. 10.3109\/15563650.2015.1035441","journal-title":"Clin Toxicol (Phila)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2012.04.001","article-title":"Risk factors for hyperammonemia associated with valproic acid therapy in adult epilepsy patients","volume":"101","author":"Yamamoto Y","year":"2012","unstructured":"Yamamoto Y, Takahashi Y, Suzuki E, et al.. Risk factors for hyperammonemia associated with valproic acid therapy in adult epilepsy patients. Epilepsy Res. 2012, 101:202-9. 10.1016\/j.eplepsyres.2012.04.001","journal-title":"Epilepsy Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/347417-severe-hyperammonemic-encephalopathy-following-sustained-release-sodium-valproate-overdose-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T01:06:41Z","timestamp":1776301601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/347417-severe-hyperammonemic-encephalopathy-following-sustained-release-sodium-valproate-overdose-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.107123","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,15]]}}}